These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical Arteries. Kopf PG; Park SK; Herrnreiter A; Krause C; Roques BP; Campbell WB Endocrinology; 2018 Jan; 159(1):238-247. PubMed ID: 29088382 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Castro CH; Santos RA; Ferreira AJ; Bader M; Alenina N; Almeida AP Hypertension; 2005 Oct; 46(4):937-42. PubMed ID: 16157793 [TBL] [Abstract][Full Text] [Related]
5. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Zhang C; Hein TW; Wang W; Kuo L Circ Res; 2003 Feb; 92(3):322-9. PubMed ID: 12595345 [TBL] [Abstract][Full Text] [Related]
6. Endothelial metabolism of angiotensin II to angiotensin III, not angiotensin (1-7), augments the vasorelaxation response in adrenal cortical arteries. Kopf PG; Campbell WB Endocrinology; 2013 Dec; 154(12):4768-76. PubMed ID: 24092640 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries. Durand MJ; Raffai G; Weinberg BD; Lombard JH Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1024-33. PubMed ID: 20656887 [TBL] [Abstract][Full Text] [Related]
8. Characterization of vasoconstrictor responses in small bovine adrenal cortical arteries in vitro. Zhang DX; Gauthier KM; Campbell WB Endocrinology; 2004 Apr; 145(4):1571-8. PubMed ID: 14726440 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway. de Godoy MA; de Oliveira AM; Rattan S J Pharmacol Exp Ther; 2004 Oct; 311(1):394-401. PubMed ID: 15178697 [TBL] [Abstract][Full Text] [Related]
11. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats. Stennett AK; Qiao X; Falone AE; Koledova VV; Khalil RA Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H745-55. PubMed ID: 19151255 [TBL] [Abstract][Full Text] [Related]
12. AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium. Wiemer G; Dobrucki LW; Louka FR; Malinski T; Heitsch H Hypertension; 2002 Dec; 40(6):847-52. PubMed ID: 12468568 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver. Herath CB; Mak K; Burrell LM; Angus PW Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G99-108. PubMed ID: 23086915 [TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Moltzer E; Verkuil AV; van Veghel R; Danser AH; van Esch JH Hypertension; 2010 Feb; 55(2):516-22. PubMed ID: 20026759 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Bautista R; Sánchez A; Hernández J; Oyekan A; Escalante B Hypertension; 2001 Sep; 38(3 Pt 2):669-73. PubMed ID: 11566953 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. Olson S; Oeckler R; Li X; Du L; Traganos F; Zhao X; Burke-Wolin T Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L559-68. PubMed ID: 15155270 [TBL] [Abstract][Full Text] [Related]
19. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Gauthier KM; Deeter C; Krishna UM; Reddy YK; Bondlela M; Falck JR; Campbell WB Circ Res; 2002 May; 90(9):1028-36. PubMed ID: 12016270 [TBL] [Abstract][Full Text] [Related]